Rociletinib (Compound)

Synonyms:Rociletinib, 1374640-70-6, CO-1686, AVL-301, CNX-419, Rociletinib (CO-1686), N-(3-((2-((4-(4-acetylpiperazin-1-yl)-2-methoxyphenyl)amino)-5-(trifluoromethyl)pyrimidin-4-yl)amino)phenyl)acrylamide, CO-1686 (AVL-301), CS-1631, N-(3-((2-((4-(4-Acetylpiperazin-1-yl)-2-methoxyphenyl)amino)-5-(trifluoromethyl)pyrimidin-4-yl)amino)phenyl)prop-2-enamide, 72AH61702G, N-[3-[[2-[4-(4-acetylpiperazin-1-yl)-2-methoxyanilino]-5-(trifluoromethyl)pyrimidin-4-yl]amino]phenyl]prop-2-enamide, Rociletinib (CO-1686, AVL-301), Rociletinib [USAN:INN], UNII-72AH61702G, N-(3-{[2-{[4-(4-Acetylpiperazin-1-yl)-2-methoxyphenyl]amino}-5-(trifluoromethyl)pyrimidin-4-yl]amino}phenyl)prop-2-enamide, CO1686, Rociletinib [USAN], CO 1686, ROCILETINIB [INN], CO-1686(Rociletinib), Rociletinib (USAN/INN), Rociletinib; CO-1686, ROCILETINIB [WHO-DD], GTPL7966, SCHEMBL4177736, CHEMBL3545308, AMY9218, EX-A228, BDBM149404, DTXSID801025958, HMS3653G08, BCP07085, MFCD26793864, NSC779405, NSC783605, NSC800872, s7284, AKOS025401943, AKOS032949985, CCG-270031, DB11907, NSC-779405, NSC-783605, NSC-800872, SB16488, NCGC00386293-08, AC-27467, AS-17009, DA-34963, HY-15729, US8975249, I-4, FT-0696686, SW219475-1, D10858, Q27088606, 2-PROPENAMIDE, N-(3-((2-((4-(4-ACETYL-1-PIPERAZINYL)-2-METHOXYPHENYL)AMINO)-5-(TRIFLUOROMETHYL)-4-PYRIMIDINYL)AMINO)PHENYL)-, N-[3-[[2-[[4-(4-Acetyl-1-piperazinyl)-2-methoxyphenyl]amino]-5-(trifluoromethyl)-4-pyrimidinyl]amino]phenyl]-2-propenamide

Pubchem:PUBCHEM:57335384

Id:e601e8de-e846-5313-b8a7-f980d819451b

Description:nan